Kiniksa Pharmaceuticals International (KNSA) Common Equity (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Common Equity of $654.15 million for Q2 2026, up 32.1% from $495.01 million a year earlier and up 8.0% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International's Common Equity came in at $567.61 million, up 29.5% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- In prior years, Kiniksa Pharmaceuticals International's Common Equity was $438.44 million in FY2024 (-0.1%), $438.84 million in FY2023 (+10.8%), $396.15 million in FY2022 (+114.1%) and $185.04 million in FY2021 (-40.7%).
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2017.
- On a year-over-year basis, Common Equity has increased in each of the last six quarters, with growth averaging 18.0% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2023, with growth of 168.2%; the weakest was Q4 2021, with a decline of 40.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $605.69 million (Q1 2026), $567.61 million (Q4 2025) and $535.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 654.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 654.15 Mn |
| Mar 31, 2026 | 605.69 Mn |
| Dec 31, 2025 | 567.61 Mn |
| Sep 30, 2025 | 535.38 Mn |
| Jun 30, 2025 | 495.01 Mn |
| Mar 31, 2025 | 457.49 Mn |
| Dec 31, 2024 | 438.44 Mn |
| Sep 30, 2024 | 437.01 Mn |
| Jun 30, 2024 | 435.10 Mn |
| Mar 31, 2024 | 431.90 Mn |
| Dec 31, 2023 | 438.84 Mn |
| Sep 30, 2023 | 405.13 Mn |
| Jun 30, 2023 | 411.66 Mn |
| Mar 31, 2023 | 390.10 Mn |
| Dec 31, 2022 | 396.15 Mn |
| Sep 30, 2022 | 384.01 Mn |
| Jun 30, 2022 | 153.49 Mn |
| Mar 31, 2022 | 166.24 Mn |
| Dec 31, 2021 | 185.04 Mn |
| Sep 30, 2021 | 214.05 Mn |
API Access
Kiniksa Pharmaceuticals International Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();